Structure of macrophage colony stimulating factor bound to FMS: Diverse signaling assemblies of class III receptor tyrosine kinases

被引:57
作者
Chen, Xiaoyan [1 ]
Liu, Heli [1 ]
Focia, Pamela J. [1 ]
Shim, Ann Hye-Ryong [1 ]
He, Xiaolin [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA
基金
美国国家卫生研究院;
关键词
growth factor; signal transduction;
D O I
10.1073/pnas.0807762105
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Macrophage colony stimulating factor (M-CSF), through binding to its receptor FMS, a class III receptor tyrosine kinase (RTK), regulates the development and function of mononuclear phagocytes, and plays important roles in innate immunity, cancer and inflammation. We report a 2.4 angstrom crystal structure of M-CSIF bound to the first 3 domains (D1-D3) of FMS. The ligand binding mode of FMS is surprisingly different from KIT, another class III RTK, in which the major ligand-binding domain of FMS, D2, uses the CD and EF loops, but not the beta-sheet on the opposite side of the Ig domain as in KIT, to bind ligand. Calorimetric data indicate that M-CSF cannot dimerize FMS without receptor-receptor interactions mediated by FMS domains D4 and D5. Consistently, the structure contains only 1 FMS-D1-D3 molecule bound to a M-CSF dimer, due to a weak, hydrophilic M-CSF:FMS interface, and probably a conformational change of the M-CSF dimer in which binding to the second site is rendered unfavorable by FMS binding at the first site. The partial, intermediate complex suggests that FMS may be activated in two steps, with the initial engagement step distinct from the subsequent dimerization/activation step. Hence, the formation of signaling class III RTK complexes can be diverse, engaging various modes of ligand recognition and various mechanistic steps for dimerizing and activating receptors.
引用
收藏
页码:18267 / 18272
页数:6
相关论文
共 30 条
[1]   Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice [J].
Aharinejad, S ;
Paulus, P ;
Sioud, M ;
Hofmann, M ;
Zins, K ;
Schäfer, R ;
Stanley, ER ;
Abraham, D .
CANCER RESEARCH, 2004, 64 (15) :5378-5384
[2]   EMERGING FAMILIES OF CYTOKINES AND RECEPTORS [J].
BAZAN, JF .
CURRENT BIOLOGY, 1993, 3 (09) :603-606
[3]   THE EFFECT OF ACTIVATING MUTATIONS ON DIMERIZATION, TYROSINE PHOSPHORYLATION AND INTERNALIZATION OF THE MACROPHAGE-COLONY-STIMULATING FACTOR-RECEPTOR [J].
CARLBERG, K ;
ROHRSCHNEIDER, L .
MOLECULAR BIOLOGY OF THE CELL, 1994, 5 (01) :81-95
[4]   Colony-stimulating factor-1 in immunity and inflammation [J].
Chitu, V ;
Stanley, ER .
CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (01) :39-48
[5]   Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects [J].
Dai, XM ;
Ryan, GR ;
Hapel, AJ ;
Dominguez, MG ;
Russell, RG ;
Kapp, S ;
Sylvestre, V ;
Stanley, ER .
BLOOD, 2002, 99 (01) :111-120
[6]   Synovial macrophage-osteoclast differentiation in inflammatory arthritis [J].
Danks, L ;
Sabokbar, A ;
Gundle, R ;
Athanasou, NA .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (10) :916-921
[7]  
DEMEYTS P, 1976, J BIOL CHEM, V251, P1877
[8]   MCDONOUGH FELINE SARCOMA-VIRUS - CHARACTERIZATION OF THE MOLECULARLY CLONED PROVIRUS AND ITS FELINE ONCOGENE (V-FMS) [J].
DONNER, L ;
FEDELE, LA ;
GARON, CF ;
ANDERSON, SJ ;
SHERR, CJ .
JOURNAL OF VIROLOGY, 1982, 41 (02) :489-500
[9]   Structure of the active core of human stem cell factor and analysis of binding to its receptor Kit [J].
Jiang, XL ;
Gurel, O ;
Mendiaz, EA ;
Stearns, GW ;
Clogston, CL ;
Lu, HS ;
Osslund, TD ;
Syed, RS ;
Langley, KE ;
Hendrickson, WA .
EMBO JOURNAL, 2000, 19 (13) :3192-3203
[10]  
Koths K, 1997, MOL REPROD DEV, V46, P31